ROBIN HOWARD W
Transaction: 07/24/2026
BUY
Change
+57,200
Price
$15.15
Filing
07/24/2026
Type
BUY
Nektar Therapeutics
NKTR • Biotechnology
$39.22
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.13B
Growth
1.5%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 4.97Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:50 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$39.22
Change0.00%
Shares Out28.92M
Market Cap$1.13B
Enterprise Value$528.40M
52W Range25.34 - 109.00
Beta1.16
P/E-7.22
P/S20.78
P/B1.26
P/FCF-4.85
EV/Sales9.68
Price$39.22
Change0.00%
Shares Out28.92M
Market Cap$1.13B
Enterprise Value$528.40M
52W Range25.34 - 109.00
Beta1.16
P/E-7.22
P/S20.78
P/B1.26
P/FCF-4.85
EV/Sales9.68
EV/EBITDA-4.11
EV/FCF-2.26
Earnings Yield-13.85%
FCF Yield-20.63%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-2.37%
Profit Margin-2.97%
Debt/Eq1.66
Current Ratio4.97
Quick Ratio4.97
Revenue 5Y1.49%
Target$121.33
Target Upside209.36%
Target Median$140.00
Target Range50.00 - 192.00
Volume609.65K
Avg Volume1.03M
EPS Surprise-0.08
Investment DNA
How strong this company looks for long-term investors
29
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
61/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
29/100
Why this score▼
Healthy liquidity · 4.97Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 33 analyst votes · 2026-10-20
76/100
Bullish
Bullish
22
Hold
6
Bearish
5
Price Target
2026-08-14
Low
$80.00
Mean
$150.00
Median
$153.00
High
$192.00
Insider Transactions
Recent executive and insider activity
Zalevsky Jonathan
Transaction: 07/24/2026
BUY
Change
+16,500
Price
$15.15
Filing
07/24/2026
Type
BUY
Zalevsky Jonathan
Transaction: 06/30/2026
SELL
Change
-5,681
Price
$70.00
Filing
07/02/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| ROBIN HOWARD W | BUY | +57,200 | $15.15 | 07/24/2026 | 07/24/2026 |
| Zalevsky Jonathan | BUY | +16,500 | $15.15 | 07/24/2026 | 07/24/2026 |
| Zalevsky Jonathan | SELL | -5,681 | $70.00 | 06/30/2026 | 07/02/2026 |
| ROBIN HOWARD W | SELL | -4,500 | $61.65 | 06/17/2026 | 06/18/2026 |
| ROBIN HOWARD W | SELL | -4,697 | $60.71 | 06/16/2026 | 06/18/2026 |
| Zalevsky Jonathan | SELL | -5,538 | $60.71 | 06/15/2026 | 06/17/2026 |
| Rubinstein Linda M | OTHER | 0 | Not reported | 05/15/2026 | 05/26/2026 |
| ROBIN HOWARD W | SELL | -444 | $65.51 | 05/19/2026 | 05/21/2026 |
| Zalevsky Jonathan | SELL | -199 | $65.51 | 05/19/2026 | 05/21/2026 |
| ROBIN HOWARD W | SELL | -423 | $73.00 | 02/18/2026 | 02/20/2026 |
| Zalevsky Jonathan | SELL | -180 | $73.00 | 02/18/2026 | 02/20/2026 |
| Zalevsky Jonathan | SELL | -3,867 | $35.67 | 01/20/2026 | 01/22/2026 |
| ROBIN HOWARD W | BUY | +21,667 | Not reported | 12/22/2025 | 12/23/2025 |
| ROBIN HOWARD W | BUY | +86,667 | $43.48 | 12/22/2025 | 12/23/2025 |
| Zalevsky Jonathan | BUY | +25,000 | $43.48 | 12/22/2025 | 12/23/2025 |
| Zalevsky Jonathan | BUY | +6,250 | Not reported | 12/22/2025 | 12/23/2025 |
| ROBIN HOWARD W | SELL | -2,207 | $54.28 | 11/25/2025 | 11/25/2025 |
| Wilson Mark Andrew | SELL | -630 | $54.28 | 11/25/2025 | 11/25/2025 |
| Zalevsky Jonathan | SELL | -1,157 | $54.28 | 11/25/2025 | 11/25/2025 |
| ROBIN HOWARD W | BUY | +12,170 | $281.25 | 11/21/2025 | 11/25/2025 |